Poolbeg Pharma’s POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office
–News Direct– Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) chief legal officer John McEvoy joins Proactive's Stephen Gunnion with news that POLB 001's Immuno-modulator II has received the fully granted patent from…